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ABSTRACT
This study investigated the hepatoprotective effects of n-hexane and ethylacetate fractions of Sida acuta against 
thioacetamide (TAA) induced hepatotoxicity in rats. Thirty-five adult male albino wistar rats, grouped into seven groups
(n=5 each) were used. Groups A-D served as the tests, while E-G served as control. The rats were fed as discussed in the 
methodology. Phyto-chemical analysis of Sida acuta was done using standard methods. Acute toxicity test revealed an 
oral LD50 of >3000 mg/kg. Test administration was oral for 7 days prior to TAA intoxication. On the 8th day, after an 
18-hour fast, TAA (200mg/kg) was injected subcutaneously to all the groups except group G (normal control). Blood 
samples were collected 24hrs after TAA administration to assess the liver function of the rats (ALT, AST, ALP and 
Albumin levels). Results revealed a significant increase in the serum levels of ALP, AST and ALT, as well as a 
significant decrease in the serum Albumin levels due to TAA induced liver damage. Pre-treatment with both n-hexane 
and ethyl acetate fractions of Sida acuta reduced the toxic effect of TAA as indicated by a decrease in the levels of 
previously elevated liver parameters and an increase in the level of Albumin. 
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INTRODUCTION
Ethno-medical studies are today recognized as the most viable methods of identifying new medicinal plants or refocusing 
on those earlier reported for their potentials based on their bioactive constituents (Farnsworth, 1996). Traditional herbal 
medicines contain naturally occurring plant substances with minimal or no industrial processing but are used in treating 
illnesses (Zaslawski, 2005). In recent times, traditional herbal medicine has gained optimum attention in global health 
debates (Chong, 2006) and Sida acuta have been recognized amongst them. The plant Sida acuta (Malvaceae) is an erect 
branched small perennial herb or shrub that grows abundantly in Nigeria. It is commonly known as wire weed because of 
the resilience of the plant. In the southern part of Nigeria, the plant is used to hasten delivery, treat malaria, jaundice and 
as anti-inflammatory agent (Okwuosa et al., 2011).
On the other hand, the human liver is a major organ involved in the metabolism of drugs, xenobiotics and toxins. During 
the metabolism, excessive free radicals are generated that may cause liver damage (Chu et al., 2002). Hepatic damage is 
associated with distortion of these metabolic functions (Wolf, 1999) consequently presenting liver diseases amongst the 
fatal diseases in the world today. They pose a serious challenge to international public health (Ashan et al., 2009). 
Majority of these diseases are not always easy to alleviate therapeutically in spite of the advances in modern medicine 
but are mostly managed (Cotran et al., 2005). 
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Liver transplantation seems to be the only effectual remedy for liver failure. Unfortunately, this technique is expensive 
and is inaccessible in most developing countries of which Nigeria is not an exception. Even in the developed country 
there is always a challenge in finding a compatible donor.
Toxins and drugs are among the basic etiopathogenetic agents of acute liver failure in western countries (Grattagliano et 
al., 2009). Drug induced liver injury is responsible for 5% of all hospital admissions and 50% of all acute liver failures 
(Ostapowicz et al., 2002). It is not surprising that hepatoprotective action against liver toxic injury remain one of the 
major challenges for clinical therapy. Of the drugs/substances that can induce hepatotoxicity is thioacetamide.
Thioacetamide is an organo-sulfur containing compound (Stankova et al., 2010). It was first reported as a hepatotoxic 
agent by fitz-hugh and Nelson (1948). A single dose of this toxin in animal can produce centrilobular necrosis with 
subsequent regenerative response (Mangipudy et al., 1995; Okuyama et al., 2003). Chronic administration can lead to 
liver cirrhosis and hepatocarcinoma (Low et al., 2004). The advantage of Thioacetamide as a model hepatotoxin consist 
in its high specificity for the liver, regiospecificity for the perivenous area and a large window of time between its 
necrogenic effect and liver failure. The injury is characterized by marked elevations in ALT and AST values with 
minimally elevated ALP. Bilirubin levels invariably are increased, and the prognosis often is worse when hepatocellular 
necrosis is accompanied by jaundice (Bahrami-Karkevandi et al., 2005).
The toxicity of Thioacetamide results from bioactivation by a mixed function oxidase system, particularly by CYP2EI 
and FAD monooxygenases (Zaragoza et al., 2000). Metabolic activation of thioacetamide then leads to the formation of 
reactive metabolites that are represented by radicals derived from thioacetamide-s-oxide (TASO) and by reactive oxygen 
species (ROS) generated as intermediate. TASO is responsible for the changes in cell permeability, increase intracellular 
concentration of Ca++, increase in nuclear volume, and also inhibits mitochondrial activity which leads to cell death and 
severely affecting those cells which are located in the perivenous acinus region (Amad et al., 2002).
Fortunately for man, nature has bestowed some plants with the property to protect, treat and cure hepatic disturbances 
with interception of fewer side effects. Such substance(s) or drugs is said to be hepatoprotective and is thus referred to as
hepatoprotective agent (Copping, 1996). Herbal drugs have more advantages than allopathic drugs as hepatoprotective 
agents because they are inexpensive, culturally acceptable, and compatible with the human body and possess minimal 
side effects Many studies have been conducted for the efficacy of Sida acuta. Hence, this study was undertaken to verify 
the folkloric claim on the use of Sida acuta as a hepatoprotective agent, using n-hexane and ethyl acetate fractions of 
Sida acuta on Thioacetamide induced liver injury in Wistar rats.
MATERIALS AND METHODS
Location and duration of study: This work was carried out in a laboratory at the University of Teaching Hospital, 
Enugu State.
Experimental Animals/Housing Conditions: Thirty-five adult male Albino Wistar rats of comparable weights (150 to 
180g) were used for this study. They were purchased from the animal house of the College of Medicine, University of 
Nigeria Teaching Hospital, Enugu, Enugu State, and allowed to acclimatize for two weeks. During the period of 
acclimatization, the animals were housed under standard temperature condition on a 12 hour light/12 hour dark cycle and 
fed with standard pellets (vitalR starter) in accordance with the institutional guidelines for the care and use of laboratory 
animals (Richard and Crawford, 2012).
Groupings: The experimental animals were divided into seven (7) groups (A, B, C, D, E, F and G) of five (5) rats each. 
Group A - D served as test groups, while group E - G served as control groups. 
Study duration: The animal’s acclimatization, substance procurement/fractionation, actual animal experiment and 
chemical analysis lasted for a period of seven months.
Substance of study/Plant collection and identification: The leaves of Sida acuta used for this study were collected 
from their natural habitat in and around Enugu between the months of January and February, 2013. A specimen of the 
plant was authenticated by a taxonomist at the Herbarium section of the Department of Botany, University of Nigeria, 
Nsukka. A voucher specimen was deposited at the Herbarium for reference (UNH/82b).
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Plant Extraction: The leaves were air dried under the shade to avoid the decomposition of phytochemical constituents. 
They were dried for about seven days after which were observed to be dried and brittle. They were ground into fine 
powder with a gasoline powered grinding machine. The dry powder was stored until needed for the fractionation process.
Fractionation of Plant Materials: The solvent fractionation was carried out using the cold maceration method in order 
of increasing polarity from n-hexane to methanol. The powdered leaves (1000g) of Sida acuta was weighed out and 
macerated in 2.5Liters of crude methanol for 24 hours. The mixture was sieved through muslin cloth and filtered using 
whatman No 1 filter paper. The Marc were spread out on McIntosh and allowed to air dry. The dried marc was 
reweighed and macerated in 2.5 liters of n-hexane for 24 hours. After 24 hours, the extract was sieved using muslin cloth 
and filtered through whatman No1. The filtrate were evaporated to dryness on a rotary evaporator (model 349/2 corning 
Ltd England) and labeled n-hexane fraction. The marc was spread out on a McIntosh and allowed to air dry.
The dried marc was reweighed and further macerated in 2.5 liters of Ethyl acetate for 24 hours after which it was sieved 
using muslin cloth and filtered through whatman No1 filter paper. The filtrate was evaporated to dryness on a rotary 
evaporator and labeled the Ethyl acetate fraction. The percentage yield of the plant fractions were 0.64% and 1.27% (w/w) 
respectively for n-hexane fraction of Sida acuta (HFSA) and ethyl acetate fraction of Sida acuta (EAFSA).
6.2g of the residue of n-hexane fraction was dissolved in 2.5% aqueous suspension of tween-80 and then made up to 
62ml with the same solvent producing a concentration of 100mg/ml of HFSA. 10g of the residue of ethyl acetate fraction 
was dissolved in 2.5% aqueous suspension of tween-80 and then made up to 100ml with the same solvent to produce a 
concentration of 100mg/ml of EAFSA.
Phyto-chemical Test: Chemical tests were carried out on the Hexane and Ethyl acetate fractions of Sida acuta for the 
qualitative determination of phytochemical constituents as described by Harborne (1998), Trease and Evans (1989) and 
Sofowora (1993) which are:
Alkaloids: 0.5 g of each plant fraction was diluted with 10 ml of acid alcohol, boiled and filtered. To 5 ml of the 
filtrate was added 2 ml of dilute ammonia. 5 ml of chloroform was added and shaken gently to extract the 
alkaloidal base. The chloroform layer was extracted with 10 ml of acetic acid. This was divided into two portions. 
Mayer’s reagent was added to one portion and Draggendoff’s reagent to the other. The formation of a cream (with 
Mayer’s reagent) or reddish brown precipitate (with Draggendoff’s reagent) was regarded as positive for the 
presence of alkaloids.   
Saponins: To 0.5 g of each of the plant fraction was added 5 ml of distilled water in a test tube. The solution was 
shaken vigorously and observed for a stable persistent froth. The frothing was mixed with 3 drops of olive oil and 
shaken vigorously. An appearance of creamy mass of small bubble indicated the presence of saponins.   
Tannins: About 0.5 g of each of the plant fractions was boiled in 10 ml of water in a test tube and then filtered. A 
few drops of 0.1% ferric chloride was added and observed for brownish green or a blue-black colouration 
indicating the presence of tannins.   
Flavonoids: About 0.5 g of each of the plant fraction was dissolved in diluted NaOH and HCl was added. A yellow 
solution that turns colourless indicated the presence of flavonoids.    
Steroids: About 0.5g of each of the plant fraction was mixed with 2ml of chloroform and concentrated H2SO4 was 
added sidewise. A red colour produced in the lower chloroform layer indicated the presence of steroids. 
Cardiac glycosides (Keller-Killiani test): To 0.5 g of each of the plant fraction was diluted to 5 ml in water. 2 ml 
of glacial acetic acid containing one drop of ferric chloride solution was added to it. This was underplayed with 
1ml of concentrated sulphuric acid. A brown ring at the interface indicated the presence of deoxysugar 
characteristic of cardenolides. A violet ring may appear below the brown ring, while in the acetic acid layer a 
greenish ring may form just above the brown ring and gradually spread throughout this layer.
Chemicals and Drugs: The methanol, n-hexane and ethyl acetate used for the extraction was manufactured by BDH 
chemicals, England. Also, the Silymarin tablets (Silybon-140 RX) used was manufactured by Micro Lab. Limited, India 
and the Thioacetamide by Sigma Chemical Co, USA. All the chemicals were of analytical grade and used without further 
purification.
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Drug Preparation and Reconstitution: Silymarin (SILYBON 140) tablets (1400mg) was dissolved in normal saline 
(8.5g/l) and made up to 100ml with normal saline to produce a final concentration of 14mg/ml. This was stored in a 
refrigerator. Thioacetamide (TAA): Thioacetamide (10g) was dissolved in distilled water and made up to 100ml with 
distilled water, producing a final concentration of 100mg/ml. This was stored at room temperature and marked toxic.
Acute Toxicity Test: A total of six of the rats were used for the acute study. The animals were divided into two groups 
A and B. After an overnight fast, group A received a single oral dose of (3000 mg/kg) of hexane fraction of Sida acuta
and group B received a single oral dose (3000 mg/kg) of ethyl acetate fraction of Sida acuta. After administration of the 
fractions, food was withheld for further 3 - 4 hours. The animals were observed individually at least once during the first 
30 minutes post-administration; periodically during first 24 hours (with special attention during the first 4 hours); and 
daily thereafter for period of 3 days. All the animals did not show lethal or toxic signs at the dose of 3000 mg/kg.
Substance administration: Oral daily administration of the fractions was done between 8am- 10am at different doses as 
follows:
1. Group A (n=5) and B (n=5) received 150mg/kg HFSA and 300mg/kg HFSA respectively, alongside normal 
feed and water ad libitum.
2. Group C (n=5) and D (n=5) received 150mg/kg EAFSA and 300mg/kg EAFSA respectively, alongside normal 
feed and water ad libitum.
3. Group E (n=5) served as the Silymarin (positive control) group and received 100mg/kg Silymarin, alongside 
normal feed and water ad libitum.
4. Group F (n=5) served as the thioacetamide (negative control group) and received thioacetamide, alongside 
normal feed and water ad libitum.
5. Group G (n=5) was the normal control group and received only normal feed and water ad libitum
The administration of the HFSA, EAFSA and Silymarin was for a period of seven (7) consecutive days. On the 8th day, 
after an 18-hour fast, 200mg/kg thioacetamide (TAA) was administered subcutaneously to groups A, B, C, D, E and F. 
Group G was not given thioacetamide (TAA) as they served as the normal control (NC).
Sample collection: Twenty four (24) hours after TAA administration, the animals (group A to G) were bled through the 
retro-orbital sinus into labeled plain tubes under ether anesthesia. The blood samples were allowed to retract and clot 
undisturbed and the sera expressed after centrifugation at 3000r.p.m for 10 minutes. The sera were transferred into 
correspondingly labeled serum containers and stored frozen for biochemical analysis.
Biochemical Analysis/methods: The sera were analyzed for liver maker enzymes, Aspartate transaminase (AST), 
Alanine transaminase (ALT), alkaline phosphatase (ALP) and Albumin (ALB). The transaminases (ALT/AST) and the 
ALP were determined by end point colorimetric method as described by Reitman and Frankel (1957) and King and King 
(1954) respectively. Albumin (ALB) estimation was determined by dye binding method as described by Doumas and 
Biggs (1972). 
Statistical analysis: The data analysis was achieved using SPSS evaluation package version 15. Results were expressed 
where appropriate as mean ± standard error of mean. Differences between mean values were determined with the one-
way analysis of variance followed by Tukey’s post-hoc comparisons with p<0.05 considered as significant.
RESULTS
Table 1 shows the mean values of serum liver hepato-specific enzymes and Albumin levels in control and experimental 
rats. A significant increase in serum ALP, AST and ALT with mean values of 157.40±0.97 IU/L, 216.80±2.80 IU/L, 
327.80±5.54 IU/L respectively were observed in thioacetamide treated group when compared with the normal control 
(group G) with mean levels of 128.00± 5.30IU/L, 81.25±9.20IU/L, 65.00±10.86IU/L for ALP, AST and ALT 
respectively (p<0.001). The mean serum Albumin level of the thioacetamide group was 2.56±0.12g/dl and this was 
significantly lower than that of the normal control (5.13±0.18 g/dl) (p<0.05).The positive control (group E) which 
received 100mg/kg dose of Silymarin showed a marked increase in mean values of serum ALP, AST and ALT of 
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151.80±3.36IU/L, 225.20±1.71IU/L and 307.40±12.83IU/L respectively when compared with the normal control 
(p<0.001).
The prophylactic administration of 150mg/kg HFSA in Group A produced a significant decrease in the serum mean level 
of ALT (184.40±15.68IU/L) when compared with the Positive (group E) and Negative (group F) controls respectively 
(p˂0.001).The Albumin level of the 150mg/kg HFSA treated group also showed a significant increase with mean values 
of 5.60±0.24g/dl when compared with the Positive control (2.75±0.85g/dl) and thioacetamide control (2.56±0.12g/dl) 
(p˂0.01). However, there was a significant increase in ALP, AST and ALT with mean values of 155.40±2.20IU/L, 
255.40±9.50IU/L and 184.40±15.68IU/L respectively in group A when compared to the normal control with mean 
values of 128.00±5.30IU/L, 81.25±9.20IU/L and 65.00±10.86IU/L for ALP, AST, ALT respectively (p˂0.001; p<0.05). 
Furthermore, Group B which received 300mg/kg HFSA had a significant decrease in mean ALT levels 
(133.60±30.85IU/L) with respect to the Positive control, and Negative control, mean values of 307.40±12.83IU/L and 
372.80±5.54IU/L respectively (p<0.001). A significant increase in mean Albumin level was observed (5.40±0.40g/dl) 
when compared with mean levels in Positive and Negative controls with mean values of 2.75±0.85g/dl and 
2.56±0.12g/dl respectively (p<0.01). A significant increase was also seen in ALP and AST with mean values of 
151.80±3.36IU/L and 236.60±30.00IU/L with respect to the mean values in Normal control with mean values of 
128.00±5.30IU/L and 81.25±9.20IU/L for ALP and AST respectively (p< 0.001).
Table 1: Effect of the fractions of Sida acuta on some hepatospecific enzyme and albumin levels of rats intoxicated 
with thioacetamide.
KEYS: a=<0.05; b=<0.01; c=<0.001 when compared with Normal Control; d=<0.05; e=<0.01; f=<0.001 with respect to 
Negative Control; g=<0.05; h=<0.01; i=<0.001 when compared with Positive Control; HFSA - Hexane fraction of Sida 
acuta; EAFSA - Ethyl acetate fraction of Sida acuta
Also, pre-treating of rats with 150mg/kg of EAFSA caused a significant decrease in ALT with mean value of 
199.80±39.97IU/L when compared with the Positive control and Negative control groups with mean ALT value of 
307.40±12.83IU/L and 372.80±5.54IU/L respectively (p<0.05 and p<0.001). In group C, there was also a significant 
increase in mean Albumin level (4.80±0.48g/dl) when compared with the Positive and Negative controls with mean 
albumin values of 2.75±0.85g/dl and 2.56±0.12g/dl respectively (p<0.05). Moreover, an increase was also observed in 
ALP, ALT and AST levels with mean values of 147.80±1.74IU/L, 199.80±39.97IU/L and 245.80±9.14IU/L respectively 
when compared with the normal control group (p<0.001).
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Group D, which received 300mg/kg of EAFSA showed a  significant increase in ALP, AST and ALT with mean values 
of 142.20±3.33IU/L, 247.40±11.88IU/L and 307.40±12.83IU/L respectively when compared with respective mean 
values in the Normal control, with mean values of 128.00±5.30IU/L (p<0.05), 81.25±9.20IU/L and 65.00±10.86 
respectively (p< 0.001). A significant decrease in ALP with the mean value 142.20±3.33IU/L was observed with respect 
to the Negative control, with the mean value of 157.40±0.97IU/L (p<0.05). It was also observed that there were no 
significant differences in Albumin value when compared with both the Positive and Negative control Groups (p>0.05).
The preliminary phytochemical analysis of both the HFSA and EAFSA revealed the presence of Alkaloids, Saponins and 
Tannins. HFSA also contain flavonoids in addition to the afore-mention compounds as presented in table 2 below.
Table 2: Preliminary phytochemical screening of leaf fractions of Sida acuta
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DISCUSSION
Thioacetamide (TAA) was chosen for this experiment because it consistently produces various grades of liver damage 
including nodular cirrhosis, liver cell proliferation, production of pseudo lobules and parenchymal cell necrosis (Mitra et 
al., 1998). In a number of animal models, TAA induced cirrhosis has a histological appearance that is more akin to 
human cirrhosis (Li et al., 2002; Mgbemena et al., 2015). Several investigators have reported that a single dose of this 
hepatotoxin can produce centrilobular hepatic necrosis and chronic administration leads to cirrhosis in rats (Khatri et al., 
2009).
Thioacetamide is a known hepatotoxin that induces liver necrosis by producing free radicals (Mohammed et al., 2009). 
In a short period of time, thioacetamide induces liver damage (Minnady et al., 2010). This toxin is metabolized by 
detoxification enzymes of p450 cytochrome system (Mohammed et al., 2009; Madani et al., 2006). Thioacetamide 
metabolites result in the production of thioacetamide-s-oxide that attacks membrane protein and lipids, changes the cell 
membrane permeability, increase intracellular calcium concentration, increase in nuclear volume and also inhibits 
mitochondrial activity which leads to cell death and severely affecting those cells which are located in the perivenous 
acinus region (Minnady et al., 2010). 
Reduced hepatic antioxidant function has also been suggested as one of the mechanism of TAA induced hepatotoxicity. 
Free radicals damage cell membrane such as those of hepatocytes which results in increasing liver enzyme activity. This 
causes the liver enzymes which are normally located inside cell cytosols to enter blood circulation. Increasing activity of 
these enzymes indicates the degree and type of liver damage (Taheri et al., 2012). 
In the present study, administration of TAA caused a decrease in albumin level compared with the normal control group 
(p<0.05). This is in agreement with results of Perez et al(2004). Decrease in the albumin level may suggest decrease in 
the synthetic function of the liver cell. However, the damage caused by TAA was ameliorated with the administration of 
HFSA and EAFSA. These show the hepatoprotective potential of the plant fractions.
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Hepatocellular damages are identified by increase in serum ALT and AST levels in that these enzymes are in the 
cytoplasm and after cellular damage; they enter blood circulation (Minnady et al., 2010). ALT is more specific to the 
liver, and is thus a better parameter for detecting liver injury (Dhorajiya and Galani, 2012). ALP is an enzyme in the cells 
lining the billiary ducts of the liver. ALP levels in serum are raised with large bile duct obstruction, intrahepatic 
cholestasis or infiltrative disease of the liver (Dhorajiya and Galani, 2012). In the present study, administration of TAA 
caused elevation of serum ALP, AST and ALT activities compared with normal control group (p<0.05). This is in 
agreement with previous data (Abul et al., 2010), which could be taken as an index of liver injury. 
The rise in ALP and ALT levels induced by TAA administration was significantly reduced in the prophylactic groups 
when compared to the TAA control group (p<0.05 and P<0.001) respectively for EAFSA and HFSA. This view is also 
supported by the works of Sreedevi et al (2009), who reported that methanolic extract of the root of Sida acuta has a 
hepatoprotective effect on paracetamol induced liver injury. However, low dose of EAFSA produced a stronger 
hepatoprotective effect than the high dose. The hepatoprotective effect of the plant fractions might be due to their effect 
against cellular leakage, loss of functional integrity of the cell membrane and the loss of stabilization of plasma 
membrane in the liver.
Earlier studies have reported the presence of biologically active compounds in Sida acuta (Jang et al., 2003) and in 
support of these studies, phytochemical analysis of the leaf fractions were carried out in the present study and these 
revealed the presence of alkaloids, saponins, flavonoids and tannins. The observed antioxidant property exhibited in vitro 
by Sida acuta in the study by Karou et al (2005) may be related to the presence of some of the afore-mentioned 
compounds as also demonstrated in previously reported studies (Ekor et al., 2010). The hepatoprotective effect of Sida 
acuta fractions against thioacetamide induced hepatotoxicity as seen in the study could be also as a result of antioxidant 
activity against the free radicals produced by thioacetamide metabolites. Antioxidants oppose the process of oxidation 
largely by neutralizing free radicals and they have potential to inhibit the oxidant chain reactions and ultimately 
reconstitute the damaged membrane (Naik, 2003).
On comparing both fractions, hexane fraction was found to be a stronger hepatoprotective agent than the corresponding 
ethyl acetate fraction against the toxicant. This may be due to the presence of flavonoids which has an inhibitory effect 
on cytochrome p450 system and prevents the further metabolism of thioacetamide which eventually lead to the reduction 
of free radical production (Cordova et al., 2002). Flavonoids also revive cells against glutathione depletion by increasing 
the capacity of antioxidant enzymes (Bahrami-karkevandi et al., 2003).
The significant increase in AST levels in the prophylactic groups (Groups A-D) may be as a result of toxic effect 
produced either by TAA or the plant fractions on the heart, brain, kidney, skeletal muscle and red blood cells. This is in 
agreement with the works of Abbasi et al (2013) who reported that single intra peritoneal injection of TAA leads to the 
distortion in red cell morphology which is characterized by increased hemoglobin concentration and decline of 
erythrocyte count.Histopathological examination of sections from rat kidneys treated with TAA showed impaired renal 
morphology throughout with severe and generalized tubular epithelial cell necrosis associated with diffuse tubular 
swelling, glomerular congestion and inflammatory cell infiltration (Kadir et al., 2013). However, in the works of Kebe et 
al (2013), chronic administration of ethanolic extracts of Sida acuta to Wistar rats resulted in decreased body weight, 
decrease bowman space, dilation of renal tubules and cellular degeneration of treated rats. 
It can then be concluded that both HFSA and EAFSA have potential hepatoprotective activity and attenuates the 
hepatotoxic effects of TAA through its antioxidant and membrane stabilizing effects. HFSA was more potent than 
EAFSA as a hepatoprotective agent. It restored the different liver functions and normal histology better than EAFSA, 
thus, these results constitute a lead towards discovering a novel herb in traditional and complementary medicine.
Further research/investigations on isolation and characterization of the active compounds responsible for the offered 
hepatoprotection by the plant fractions as well as chronic toxicity studies on the plant fractions should be carried out. 
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